跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AZ191
首页
药物
AZ191
AZ191
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
AZ191 intermediate, preparation method and preparation method of AZ191
申请人: SHANGHAI LINKCHEM TECH CO LTD
优先权: 2024
CN
AZ191的药物新用途
申请人: 忻佑康医药科技(南京)有限公司
优先权: 2020
CN
Application of DYRK1B inhibitor AZ191 in preparation of medicine for treating and preventing liver injury
申请人: AFFILIATED HOSPITAL OF NANTONG UNIV
优先权: 2025
CN
Core-shell structure drug-loaded magnetic-thermal hydrogel microsphere for treating drug-resistant ovarian cancer and preparation method thereof
申请人: UNIV DALIAN TECH
优先权: 2024
CN
Pyridyl piperazine derivative as well as preparation method and application thereof
申请人: UNIV HUNAN NORMAL
优先权: 2024
CN
药物
反馈